A Novel Risk Factor for Para-Aortic Lymph Node Recurrence After Definite Pelvic Radiotherapy in Stage IIIB Cervical Cancer
Background: Studies determining which patients with International Federation of Gynecology and Obstetrics (FIGO) stage IIIB disease benefit from prophylactic extended-field irradiation (EFRT), which can reduce para-aortic lymph node (PALN) failure rates, are limited. The study was designed to evalua...
Main Authors: | Guangyu Zhang MD, Cong Wang MD, Changdong Ma PhD, MD, Li Miao MD, Fangfang He MD, Chunli Fu PhD, MD |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2022-11-01
|
Series: | Technology in Cancer Research & Treatment |
Online Access: | https://doi.org/10.1177/15330338221141541 |
Similar Items
-
Ovarian Function Preservation in Patients With Cervical Cancer Undergoing Hysterectomy and Ovarian Transposition Before Pelvic Radiotherapy
by: Wonguen Jung MD, PhD, et al.
Published: (2021-10-01) -
Cervical lymph node metastasis as the first and only manifestation of prostatic adenocarcinoma
by: Tadashi Terada, MD, PhD
Published: (2015-12-01) -
Sentinel lymph node imaging guided IMRT for prostate cancer: Individualized pelvic radiation therapy versus RTOG guidelines
by: Chien P. Chen, MD, PhD, et al.
Published: (2016-01-01) -
Prediction of Cervical Lymph Node Metastasis Using MRI Radiomics Approach in Papillary Thyroid Carcinoma: A Feasibility Study
by: Heng Zhang MD, et al.
Published: (2020-11-01) -
Type IIIB endoleak from stent suture lines of a thoracic endograft
by: Kyokun Uehara, MD, PhD, et al.
Published: (2019-09-01)